How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How to predict response to anti-tumour necrosis factor agents in inflammatory bowel disease

Published:2018-07-06 Issue:8 Volume:12 Page:797-810
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Naviglio Samuele¹²^ORCID,Giuffrida Paolo³,Stocco Gabriele⁴,Lenti Marco Vincenzo³,Ventura Alessandro¹²,Corazza Gino Roberto³,Di Sabatino Antonio³

Affiliation:

1. Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy

2. Department of Medicine, Surgery, and Health Sciences, University of Trieste, Trieste, Italy

3. First Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy

4. Department of Life Science, University of Trieste, Trieste, Italy

Funder

not

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2018.1494573

Reference153 articles.

1. Cytokines in inflammatory bowel disease

2. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease

3. Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

4. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

5. Infliximab Reduces Hospitalizations and Surgery Interventions in Patients With Inflammatory Bowel Disease

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. HLA-DQA1*05 correlates with increased risk of anti-drug antibody development and reduced response to infliximab in Chinese patients with Crohn’s disease;Gastroenterology Report;2023-12-22

3. Mucosal α4β7+ Lymphocytes and MAdCAM+ Venules Predict Response to Vedolizumab in Ulcerative Colitis;Inflammatory Bowel Diseases;2023-07-12

4. Inflammatory Studies of Dehydroandrographolide: Isolation, Spectroscopy, Biological Activity, and Theoretical Modeling;Applied Biochemistry and Biotechnology;2023-05-04

5. Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort;International Journal of Molecular Sciences;2023-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3